IM Cannabis (IMCC) Free Cash Flow Growth (1y) (2021 - 2026)
IM Cannabis (IMCC) Free Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 10.34% |
| 3 | Zoetis | 32.57 Bn | 30.63 Bn | 1.62 Bn | -13.65% |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | 56.40% |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn | -5.85% |
| 6 | RedHill Biopharma | 22.43 Bn | 22.43 Bn | - | - |
| 7 | Viatris | 20.23 Bn | 18.42 Bn | 1.16 Bn | -29.32% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | 166.91% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 44.93% |
| 10 | IM Cannabis | 524,339.20 | -207,783.32 | 1.03 Mn | -104.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -104.24% |
| Dec 31, 2025 | 193.98% |
| Sep 30, 2025 | -222.47% |
| Jun 30, 2025 | -144.69% |
| Mar 31, 2025 | 768.45% |
| Dec 31, 2024 | -223.00% |
| Sep 30, 2024 | -48.10% |
| Jun 30, 2024 | 114.67% |
| Mar 31, 2024 | 88.87% |
| Dec 31, 2023 | 42.42% |
| Sep 30, 2023 | 366.39% |
| Jun 30, 2023 | -508.65% |
| Mar 31, 2023 | 39.58% |
| Dec 31, 2022 | -164.49% |
| Sep 30, 2022 | 105.10% |
| Jun 30, 2022 | 92.63% |
| Mar 31, 2022 | -27.33% |
| Dec 31, 2021 | 1,054.47% |
| Sep 30, 2021 | -1,283.59% |
| Jun 30, 2021 | -470.15% |